ARTICLE | Company News
Diaxonhit, InnaVirVax, Institut National de la Sante et de la Recherche Medicale (INSERM) infectious, diagnostic news
May 5, 2014 7:00 AM UTC
InnaVirVax said it will receive €6.3 million ($8.7 million) over five years from French public agency Bpifrance under the Strategic Industrial Innovation program to fund development of HIV vaccine V...